| scholarly article | Q13442814 |
| P356 | DOI | 10.1309/3G1X-DX0D-VHBN-VKB4 |
| P698 | PubMed publication ID | 16191510 |
| P2093 | author name string | Carlos E Bueso-Ramos | |
| Pei Lin | |||
| L Jeffrey Medeiros | |||
| Sergej Konoplev | |||
| Jeffrey L Jorgensen | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 414-420 | |
| P577 | publication date | 2005-09-01 | |
| P1433 | published in | American Journal of Clinical Pathology | Q15750224 |
| P1476 | title | Immunophenotypic profile of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia | |
| P478 | volume | 124 |
| Q90203265 | A case of AL amyloidosis associated with follicular lymphoma with plasmacytic differentiation |
| Q45298830 | B-cell neoplasms with plasmacellular and plasmablastic differentiation |
| Q39093915 | Bone marrow micro-environment is a crucial player for myelomagenesis and disease progression. |
| Q49151446 | CD5-positive follicular lymphoma: clinicopathologic correlations and outcome in 88 cases |
| Q64092288 | Central Nervous System Involvement by Waldenstrom Macroglobulinemia: A Case Report of the Bing-Neel Syndrome |
| Q28301328 | Characterization of subpopulation lacking both B-cell and plasma cell markers in Waldenstrom macroglobulinemia cell line |
| Q64967151 | Clinical Presentation and Gene Expression Profiling of Immunoglobulin M Multiple Myeloma Compared With Other Myeloma Subtypes and Waldenström Macroglobulinemia. |
| Q51768923 | Clinicopathologic significance of loss of CD19 expression in diffuse large B-cell lymphoma. |
| Q37626783 | Flow cytometric differentiation of abnormal and normal plasma cells in the bone marrow in patients with multiple myeloma and its precursor diseases |
| Q48987219 | High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders |
| Q92482940 | IgA-producing lymphoplasmacytic lymphoma carrying the chromosomal abnormality t(8;14) |
| Q35597598 | Immunophenotyping of Waldenströms macroglobulinemia cell lines reveals distinct patterns of surface antigen expression: potential biological and therapeutic implications |
| Q41876531 | Lymphoplasmacytic non-Hodgkin lymphoma/Waldenström's macroglobulinemia with CD5+, CD23+, and CD10-. |
| Q26766718 | Monoclonal antibodies targeting CD38 in hematological malignancies and beyond |
| Q43709838 | Multiparameter flow cytometry for the identification of the Waldenström's clone in IgM-MGUS and Waldenström's Macroglobulinemia: new criteria for differential diagnosis and risk stratification |
| Q43100876 | Persistent monotypic plasma cells with absence of neoplastic B cell component in a treated case of waldenström macroglobulinemia: a sign of residual disease? |
| Q37683315 | Plasma cell leukemia with t(11;14)(q13;q32) simulating lymphoplasmacytic lymphoma - a diagnostic challenge solved by flow cytometry |
| Q37499211 | Recommendations for the diagnosis and initial evaluation of patients with Waldenström Macroglobulinaemia: A Task Force from the 8th International Workshop on Waldenström Macroglobulinaemia |
| Q38794082 | Requirement of CXCL12-CXCR7 signaling for CD20(-) CD138(-) double-negative population in lymphoplasmacytic lymphoma |
| Q27314737 | Targeted inhibition of the deubiquitinating enzymes, USP14 and UCHL5, induces proteotoxic stress and apoptosis in Waldenström macroglobulinaemia tumour cells |
| Q41578682 | Utility of quantitative flow cytometry immunophenotypic analysis of CD5 expression in small B-cell neoplasms |
| Q35002178 | VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy |
| Q35009892 | Waldenstrom macroglobulinemia with CD5+ expression presented as cryoglobulinemic glomerulonephropathy: a case report |
| Q47736653 | Waldenstrom's Macroglobulinemia: An Update |
| Q85509713 | [Clinical and biological characteristics of non-IgM lymphoplasmacytic lymphoma] |
Search more.